Faheem Younus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Faheem Younus has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Marcos Wolff
Section of Infectious Diseases at Franklin Square Hospital, University of Maryland, Baltimore, MD, USA
1 shared publicationMichelle Bahrain
Johns Hopkins University Hospital, Baltimore, MD, USA
1 shared publicationMinas Vasiliades
Section of Infectious Diseases at Franklin Square Hospital, Baltimore, MD
1 shared publicationVasilios Pyrgos
Department of Medicine, Franklin Square Hospital Center, Baltimore, MD, USA
1 shared publication
Latest Publications
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 38 (8) , 702-707
Five cases of bacterial endocarditis after furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus aureus infections
Bacterial endocarditis secondary to Panton-Valentine leukocidin producing community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections is rare. We report 5 previously healthy patients who presented with endocarditis after developing furunculosis due to CA-MRSA. A retrospective chart review of all patients with MRSA positive blood cultures was conducted over a 12-month period. Patients with multiple positive blood cultures within 72 h of admission and who had no risk factors for MRSA acquisition were included. Modified Duke's criteria were used to define bacterial endocarditis. PCR detection of Panton-Valentine leukocidin (PVL) genes as well as SCCmec typing was performed. In addition, strain typing of MRSA isolates was performed utilizing pulsed-field gel electrophoresis. Five out of a total of 193 patients had features consistent with CA-MRSA infections and met modified Duke's criteria for bacterial endocarditis. Blood culture isolates were found to be PVL gene positive and carried the type IV SCCmec element. PFGE confirmed that skin isolate was identical to the isolate cultured from his blood. Bacterial endocarditis in patients with CA-MRSA furunculosis is an emerging entity. In areas where CA-MRSA skin infections are prevalent, inappropriate initial antibiotics remain a major problem and may result in significant morbidity.
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 38 (8) , 702-707
Five cases of bacterial endocarditis after furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus aureus infections
Bacterial endocarditis secondary to Panton-Valentine leukocidin producing community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections is rare. We report 5 previously healthy patients who presented with endocarditis after developing furunculosis due to CA-MRSA. A retrospective chart review of all patients with MRSA positive blood cultures was conducted over a 12-month period. Patients with multiple positive blood cultures within 72 h of admission and who had no risk factors for MRSA acquisition were included. Modified Duke's criteria were used to define bacterial endocarditis. PCR detection of Panton-Valentine leukocidin (PVL) genes as well as SCCmec typing was performed. In addition, strain typing of MRSA isolates was performed utilizing pulsed-field gel electrophoresis. Five out of a total of 193 patients had features consistent with CA-MRSA infections and met modified Duke's criteria for bacterial endocarditis. Blood culture isolates were found to be PVL gene positive and carried the type IV SCCmec element. PFGE confirmed that skin isolate was identical to the isolate cultured from his blood. Bacterial endocarditis in patients with CA-MRSA furunculosis is an emerging entity. In areas where CA-MRSA skin infections are prevalent, inappropriate initial antibiotics remain a major problem and may result in significant morbidity.
- 8 July 2004
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 36 (6-7) , 509-512
High-Dose Steroids in the Management of Acute Flaccid Paralysis Due To West Nile Virus Infection
Despite an increasing incidence of severe neurological disease due to West Nile virus, supportive care remains the mainstay of treatment. We present the first report of WNV induced acute flaccid paralysis successfully treated with high-dose corticosteroid therapy.
- 8 July 2004
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 36 (6-7) , 509-512
High-Dose Steroids in the Management of Acute Flaccid Paralysis Due To West Nile Virus Infection
Despite an increasing incidence of severe neurological disease due to West Nile virus, supportive care remains the mainstay of treatment. We present the first report of WNV induced acute flaccid paralysis successfully treated with high-dose corticosteroid therapy.